Merck & Co., Inc.

NYSE:MRK

Pharmaceutical Preparations·RAHWAY, NJ

, Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey.

CFO

Litchfield Caroline

Summary Financials

Revenue

$60.1B

+1.4% YoY

FY 2025

Adj. EBITDA

—

Net Income

$365.0M

0.6% margin

FY 2025

EPS (Diluted)

$0.14

FY 2025

Stock Price

$115.43

-0.2%

2026-03-16

52W Range

$73.31 – $125.14

P/E Ratio

824.5x

Market Cap

$285.4B

Cash

$13.2B

FY 2025

Total Debt

$37.1B

FY 2025

Net Debt

$23.9B

FY 2025

Enterprise Value

$309.3B

Debt / EBITDA

—

EV / EBITDA

—

Employees

—

, Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey.

CFO

Litchfield Caroline

Revenue

$60.1B

+1.4% YoY

FY 2025

Adj. EBITDA

—

Net Income

$365.0M

0.6% margin

FY 2025

EPS (Diluted)

$0.14

FY 2025

Stock Price

$115.43

-0.2%

2026-03-16

52W Range

$73.31 – $125.14

P/E Ratio

824.5x

Market Cap

$285.4B

Cash

$13.2B

FY 2025

Total Debt

$37.1B

FY 2025

Net Debt

$23.9B

FY 2025

Enterprise Value

$309.3B

Debt / EBITDA

—

EV / EBITDA

—

Employees

—